AVE 0.00% 0.3¢ avecho biotechnology limited

mass market personal care, page-3

  1. 55 Posts.
    I can see poh's range of personal care products being the making of the company, especially if they expand into male market as well. While the personal care market may seem saturated what poh has is TPM and that makes poh products supersede everything on the market. Also the patches (which will be blockbusters) are still being worked on whereas Elixia is out there and being raved about if the comments posted on another thread are to be believed. I like the prospect that Elixia would be able to fund poh's R&D lessening the need for capital raising. The amount that us women spend on this stuff, and what men would pay to avoid baldness is huge, so yep i recon that personal care products could beat Oxy as the company maker:)
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.985K 661.6K

Buyers (Bids)

No. Vol. Price($)
56 86992113 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 60266880 16
View Market Depth
Last trade - 10.00am 30/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.